Entity Details

Primary name FAH
Entity type gene
Source Source Link

Details

PrimaryID2184
RefseqGeneNG_012833
SymbolFAH
Namefumarylacetoacetate hydrolase
Chromosome15
Location15q25.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2001-05-24
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsFAAA_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004334 fumarylacetoacetase activity
GO:0005829 cytosol
GO:0006527 arginine catabolic process
GO:0006559 L-phenylalanine catabolic process
GO:0006572 tyrosine catabolic process
GO:0046872 metal ion binding
GO:0070062 extracellular exosome
GO:1902000 homogentisate catabolic process

Diseases

Show/Hide Table
Disease IDSourceNameDescription
276700 OMIMTyrosinemia 1 (TYRSN1)An inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include hepatic necrosis, renal tubular injury, episodic weakness, self-mutilation, and seizures. Renal tubular dysfunction is associated with phosphate loss and hypophosphataemic rickets. Progressive liver disease can lead to the development of hepatocellular carcinoma. Dietary treatment with restriction of tyrosine and phenylalanine alleviates the rickets, but liver transplantation has so far been the only definite treatment. The disease is caused by variants affecting the gene represented in this entry.

Interactions

15 interactions